Rain Oncology Inc. Reported Earnings

Rain Oncology Inc. (RAIN) reported a loss of $0.40 per share on revenue of $0.00 million for the . .

Rain Oncology Inc. is a late-stage precision oncology company developing therapies that target oncogenic drivers for which it is able to genetically select patients it believes will most likely benefit.